Diabetes
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Auboeuf, D.
Right arrow Articles by Vidal, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Auboeuf, D.
Right arrow Articles by Vidal, H.
Social Bookmarking
Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Diabetes, Vol 46, Issue 8 1319-1327, Copyright © 1997 by American Diabetes Association

ARTICLES

Tissue distribution and quantification of the expression of mRNAs of peroxisome proliferator-activated receptors and liver X receptor-alpha in humans: no alteration in adipose tissue of obese and NIDDM patients

D Auboeuf, J Rieusset, L Fajas, P Vallier, V Frering, JP Riou, B Staels, J Auwerx, M Laville and H Vidal
Institut National de la Sante et de la Recherche Medicale (INSERM) U.449 and Lyon Human Nutrition Research Center, R. Laennec Faculty of Medicine, France.

Members of the peroxisome proliferator-activated receptor (PPAR) family might be involved in pathologies with altered lipid metabolism. They participate in the control of the expression of genes involved in lipid metabolism and adipocyte differentiation. In addition, thiazolidinediones improve insulin resistance in vivo by activating PPAR gamma. However, little is known regarding their tissue distribution and relative expression in humans. Using a quantitative and sensitive reverse transcription (RT)-competitive polymerase chain reaction (PCR) assay, we determined the distribution and relative mRNA expression of the four PPARs (alpha,beta, gamma1, and gamma2) and liver X receptor-alpha (LXR alpha) in the main tissues implicated in lipid metabolism. PPAR alpha and LXR alpha were mainly expressed in liver, while PPAR gamma1 predominated in adipose tissue and large intestine. We found that PPAR gamma2 mRNA was a minor isoform, even in adipose tissue, thus causing question of its role in humans. PPAR beta mRNA was present in all the tissues tested at low levels. In addition, PPAR gamma mRNA was barely detectable in skeletal muscle, suggesting that improvement of insulin resistance with thiazolidinediones may not result from a direct effect of these agents on PPAR gamma in muscle. Obesity and NIDDM were not associated with change in PPARs and LXR alpha expression in adipose tissue. The mRNA levels of PPAR gamma1, the predominant form in adipocytes, did not correlate with BMI, leptin mRNA levels, or fasting insulinemia in 29 subjects with various degrees of obesity. These results indicated that obesity is not associated with alteration in PPAR gene expression in abdominal subcutaneous adipose tissue in humans.
Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
 Physiol. GenomicsHome page
W. Su, C. R. Bush, B. M. Necela, S. R. Calcagno, N. R. Murray, A. P. Fields, and E. A. Thompson
Differential expression, distribution, and function of PPAR-{gamma} in the proximal and distal colon
Physiol Genomics, August 20, 2007; 30(3): 342 - 353.
[Abstract] [Full Text] [PDF]

Home page
 Drug Metab. Dispos.Home page
K. Senekeo-Effenberger, S. Chen, E. Brace-Sinnokrak, J. A. Bonzo, M.-F. Yueh, U. Argikar, J. Kaeding, J. Trottier, R. P. Remmel, J. K. Ritter, et al.
Expression of the Human UGT1 Locus in Transgenic Mice by 4-Chloro-6-(2,3-xylidino)-2-pyrimidinylthioacetic Acid (WY-14643) and Implications on Drug Metabolism through Peroxisome Proliferator-Activated Receptor {alpha} Activation
Drug Metab. Dispos., March 1, 2007; 35(3): 419 - 427.
[Abstract] [Full Text] [PDF]

Home page
 Toxicol SciHome page
M. L. Takacs and B. D. Abbott
Activation of Mouse and Human Peroxisome Proliferator-Activated Receptors ({alpha}, {beta}/{delta}, {gamma}) by Perfluorooctanoic Acid and Perfluorooctane Sulfonate
Toxicol. Sci., January 1, 2007; 95(1): 108 - 117.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
G. Kristiansen, J. Jacob, A.-C. Buckendahl, R. Grutzmann, I. Alldinger, B. Sipos, G. Kloppel, M. Bahra, J. M. Langrehr, P. Neuhaus, et al.
Peroxisome Proliferator-Activated Receptor {gamma} Is Highly Expressed in Pancreatic Cancer and Is Associated With Shorter Overall Survival Times.
Clin. Cancer Res., November 1, 2006; 12(21): 6444 - 6451.
[Abstract] [Full Text] [PDF]

Home page
 J Am Coll CardiolHome page
A. J. Gilde, J.-C. Fruchart, and B. Staels
Peroxisome Proliferator-Activated Receptors at the Crossroads of Obesity, Diabetes, and Cardiovascular Disease
J. Am. Coll. Cardiol., October 27, 2006; 48(9_Suppl_A): A24 - A32.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
T. Tchkonia, N. Giorgadze, T. Pirtskhalava, T. Thomou, M. DePonte, A. Koo, R. A. Forse, D. Chinnappan, C. Martin-Ruiz, T. von Zglinicki, et al.
Fat Depot-Specific Characteristics Are Retained in Strains Derived From Single Human Preadipocytes
Diabetes, September 1, 2006; 55(9): 2571 - 2578.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
I. Pruimboom-Brees, M. Haghpassand, L. Royer, D. Brees, C. Aldinger, W. Reagan, J. Singh, R. Kerlin, C. Kane, S. Bagley, et al.
A Critical Role for Peroxisomal Proliferator-Activated Receptor-{alpha} Nuclear Receptors in the Development of Cardiomyocyte Degeneration and Necrosis
Am. J. Pathol., September 1, 2006; 169(3): 750 - 760.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
N. K. LeBrasseur, M. Kelly, T.-S. Tsao, S. R. Farmer, A. K. Saha, N. B. Ruderman, and E. Tomas
Thiazolidinediones can rapidly activate AMP-activated protein kinase in mammalian tissues
Am J Physiol Endocrinol Metab, July 1, 2006; 291(1): E175 - E181.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Gastrointest. Liver Physiol.Home page
N. Sato, F. A. Moore, B. C. Kone, L. Zou, M. A. Smith, M. A. Childs, S. Moore-Olufemi, S. G. Schultz, and R. A. Kozar
Differential induction of PPAR-{gamma} by luminal glutamine and iNOS by luminal arginine in the rodent postischemic small bowel
Am J Physiol Gastrointest Liver Physiol, April 1, 2006; 290(4): G616 - G623.
[Abstract] [Full Text] [PDF]

Home page
 J. Lipid Res.Home page
U. Edvardsson, A. Ljungberg, D. Linden, L. William-Olsson, H. Peilot-Sjogren, A. Ahnmark, and J. Oscarsson
PPAR{alpha} activation increases triglyceride mass and adipose differentiation-related protein in hepatocytes
J. Lipid Res., February 1, 2006; 47(2): 329 - 340.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes CareHome page
N. K. LeBrasseur and N. B. Ruderman
Why Might Thiazolidinediones Increase Exercise Capacity in Patients With Type 2 Diabetes?
Diabetes Care, December 1, 2005; 28(12): 2975 - 2977.
[Full Text] [PDF]

Home page
 DiabetesHome page
A. Tsuchida, T. Yamauchi, S. Takekawa, Y. Hada, Y. Ito, T. Maki, and T. Kadowaki
Peroxisome Proliferator-Activated Receptor (PPAR){alpha} Activation Increases Adiponectin Receptors and Reduces Obesity-Related Inflammation in Adipose Tissue: Comparison of Activation of PPAR{alpha}, PPAR{gamma}, and Their Combination
Diabetes, December 1, 2005; 54(12): 3358 - 3370.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
A. M. Schwab, S. Granholm, E. Persson, B. Wilkes, U. H. Lerner, and H. H. Conaway
Stimulation of Resorption in Cultured Mouse Calvarial Bones by Thiazolidinediones
Endocrinology, October 1, 2005; 146(10): 4349 - 4361.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Pharmacol.Home page
J. P. Singh, R. Kauffman, W. Bensch, G. Wang, P. McClelland, J. Bean, C. Montrose, N. Mantlo, and A. Wagle
Identification of a Novel Selective Peroxisome Proliferator-Activated Receptor {alpha} Agonist, 2-Methyl-2-(4-{3-[1-(4-methylbenzyl)-5-oxo-4,5-dihydro-1H-1,2,4-triazol-3-yl]propyl}phenoxy)propanoic Acid (LY518674), That Produces Marked Changes in Serum Lipids and Apolipoprotein A-1 Expression
Mol. Pharmacol., September 1, 2005; 68(3): 763 - 768.
[Abstract] [Full Text] [PDF]

Home page
 Reproductive SciencesHome page
V. A. Rodie, A. Young, F. Jordan, N. Sattar, I. A. Greer, and D. J. Freeman
Human Placental Peroxisome Proliferator-Activated Receptor {delta} and {gamma} Expression in Healthy Pregnancy and in Preeclampsia and Intrauterine Growth Restriction
Reproductive Sciences, July 1, 2005; 12(5): 320 - 329.
[Abstract] [PDF]

Home page
 Mol. Pharmacol.Home page
A. Lampen, P. A. Grimaldi, and H. Nau
Modulation of Peroxisome Proliferator-Activated Receptor {delta} Activity Affects Neural Cell Adhesion Molecule and Polysialyltransferase ST8SiaIV Induction by Teratogenic Valproic Acid Analogs in F9 Cell Differentiation
Mol. Pharmacol., July 1, 2005; 68(1): 193 - 203.
[Abstract] [Full Text] [PDF]

Home page
 Circ. Res.Home page
F. Blaschke, O. Leppanen, Y. Takata, E. Caglayan, J. Liu, M. C. Fishbein, K. Kappert, K. I. Nakayama, A. R. Collins, E. Fleck, et al.
Liver X Receptor Agonists Suppress Vascular Smooth Muscle Cell Proliferation and Inhibit Neointima Formation in Balloon-Injured Rat Carotid Arteries
Circ. Res., December 10, 2004; 95(12): e110 - e123.
[Abstract] [Full Text] [PDF]

Home page
 J Mol EndocrinolHome page
K. R Steffensen, S. Y. Neo, T. M Stulnig, V. B Vega, S. S Rahman, G. U Schuster, J.-A. Gustafsson, and E. T Liu
Genome-wide expression profiling; a panel of mouse tissues discloses novel biological functions of liver X receptors in adrenals
J. Mol. Endocrinol., December 1, 2004; 33(3): 609 - 622.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
T. C. McCarthy, P. T. Pollak, E. A. Hanniman, and C. J. Sinal
Disruption of Hepatic Lipid Homeostasis in Mice after Amiodarone Treatment Is Associated with Peroxisome Proliferator-Activated Receptor-{alpha}Target Gene Activation
J. Pharmacol. Exp. Ther., December 1, 2004; 311(3): 864 - 873.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
K. Al-Shali, H. Cao, N. Knoers, A. R. Hermus, C. J. Tack, and R. A. Hegele
A Single-Base Mutation in the Peroxisome Proliferator-Activated Receptor {gamma}4 Promoter Associated with Altered in Vitro Expression and Partial Lipodystrophy
J. Clin. Endocrinol. Metab., November 1, 2004; 89(11): 5655 - 5660.
[Abstract] [Full Text] [PDF]

Home page
 J. Am. Soc. Nephrol.Home page
Y. Guan
Peroxisome Proliferator-Activated Receptor Family and Its Relationship to Renal Complications of the Metabolic Syndrome
J. Am. Soc. Nephrol., November 1, 2004; 15(11): 2801 - 2815.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
M. Z. Strowski, Z. Li, D. Szalkowski, X. Shen, X.-M. Guan, S. Juttner, D. E. Moller, and B. B. Zhang
Small-Molecule Insulin Mimetic Reduces Hyperglycemia and Obesity in a Nongenetic Mouse Model of Type 2 Diabetes
Endocrinology, November 1, 2004; 145(11): 5259 - 5268.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
D. Seboek, P. Linscheid, H. Zulewski, I. Langer, M. Christ-Crain, U. Keller, and B. Muller
Somatostatin Is Expressed and Secreted by Human Adipose Tissue upon Infection and Inflammation
J. Clin. Endocrinol. Metab., October 1, 2004; 89(10): 4833 - 4839.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Endocrinol.Home page
J. Rieusset, J. Seydoux, S. I. Anghel, P. Escher, L. Michalik, N. Soon Tan, D. Metzger, P. Chambon, W. Wahli, and B. Desvergne
Altered Growth in Male Peroxisome Proliferator-Activated Receptor {gamma} (PPAR{gamma}) Heterozygous Mice: Involvement of PPAR{gamma} in a Negative Feedback Regulation of Growth Hormone Action
Mol. Endocrinol., October 1, 2004; 18(10): 2363 - 2377.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
M. Tiikkainen, A.-M. Hakkinen, E. Korsheninnikova, T. Nyman, S. Makimattila, and H. Yki-Jarvinen
Effects of Rosiglitazone and Metformin on Liver Fat Content, Hepatic Insulin Resistance, Insulin Clearance, and Gene Expression in Adipose Tissue in Patients With Type 2 Diabetes
Diabetes, August 1, 2004; 53(8): 2169 - 2176.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
F. Bogazzi, F. Ultimieri, F. Raggi, D. Russo, R. Vanacore, C. Guida, S. Brogioni, C. Cosci, M. Gasperi, L. Bartalena, et al.
Growth Hormone Inhibits Apoptosis in Human Colonic Cancer Cell Lines: Antagonistic Effects of Peroxisome Proliferator Activated Receptor-{gamma} Ligands
Endocrinology, July 1, 2004; 145(7): 3353 - 3362.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
Q. Shen, G. W. Cline, G. I. Shulman, M. D. Leibowitz, and P. J. A. Davies
Effects of Rexinoids on Glucose Transport and Insulin-mediated Signaling in Skeletal Muscles of Diabetic (db/db) Mice
J. Biol. Chem., May 7, 2004; 279(19): 19721 - 19731.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
H.-i. Kim and Y.-h. Ahn
Role of Peroxisome Proliferator-Activated Receptor-{gamma} in the Glucose-Sensing Apparatus of Liver and {beta}-Cells
Diabetes, February 1, 2004; 53(90001): S60 - 65.
[Abstract] [Full Text]

Home page
 EndocrinologyHome page
P. Linscheid, D. Seboek, E. S. Nylen, I. Langer, M. Schlatter, K. L. Becker, U. Keller, and B. Muller
In Vitro and in Vivo Calcitonin I Gene Expression in Parenchymal Cells: A Novel Product of Human Adipose Tissue
Endocrinology, December 1, 2003; 144(12): 5578 - 5584.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
K. T. Dalen, S. M. Ulven, K. Bamberg, J.-A. Gustafsson, and H. I. Nebb
Expression of the Insulin-responsive Glucose Transporter GLUT4 in Adipocytes Is Dependent on Liver X Receptor {alpha}
J. Biol. Chem., November 28, 2003; 278(48): 48283 - 48291.
[Abstract] [Full Text] [PDF]

Home page
 GutHome page
L Jackson, W Wahli, L Michalik, S A Watson, T Morris, K Anderton, D R Bell, J A Smith, C J Hawkey, and A J Bennett
Potential role for peroxisome proliferator activated receptor (PPAR) in preventing colon cancer
Gut, September 1, 2003; 52(9): 1317 - 1322.
[Abstract] [Full Text]

Home page
 DiabetesHome page
E. H. Koh, M.-S. Kim, J.-Y. Park, H. S. Kim, J.-Y. Youn, H.-S. Park, J. H. Youn, and K.-U. Lee
Peroxisome Proliferator-Activated Receptor (PPAR)-{alpha} Activation Prevents Diabetes in OLETF Rats: Comparison With PPAR-{gamma} Activation
Diabetes, September 1, 2003; 52(9): 2331 - 2337.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
F. Bogazzi, F. Ultimieri, F. Raggi, D. Russo, P. Viacava, D. Cecchetti, A. Costa, S. Brogioni, C. Cosci, M. Gasperi, et al.
Changes in the Expression of the Peroxisome Proliferator-Activated Receptor {gamma} Gene in the Colonic Polyps and Colonic Mucosa of Acromegalic Patients
J. Clin. Endocrinol. Metab., August 1, 2003; 88(8): 3938 - 3942.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
V. Giusti, C. Verdumo, M. Suter, R. C. Gaillard, P. Burckhardt, and F. Pralong
Expression of Peroxisome Proliferator-Activated Receptor-{gamma}1 and Peroxisome Proliferator-Activated Receptor-{gamma}2 in Visceral and Subcutaneous Adipose Tissue of Obese Women
Diabetes, July 1, 2003; 52(7): 1673 - 1676.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
G. A. Francis, J.-S. Annicotte, and J. Auwerx
PPAR-{alpha} effects on the heart and other vascular tissues
Am J Physiol Heart Circ Physiol, June 5, 2003; 285(1): H1 - H9.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
T. K. T. Lam, A. Carpentier, G. F. Lewis, G. van de Werve, I. G. Fantus, and A. Giacca
Mechanisms of the free fatty acid-induced increase in hepatic glucose production
Am J Physiol Endocrinol Metab, May 1, 2003; 284(5): E863 - E873.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
S. Li, W. Chen, S. R. Srinivasan, E. Boerwinkle, and G. S. Berenson
The Peroxisome Proliferator-Activated Receptor-{gamma}2 Gene Polymorphism (Pro12Ala) Beneficially Influences Insulin Resistance and Its Tracking From Childhood to Adulthood: The Bogalusa Heart Study
Diabetes, May 1, 2003; 52(5): 1265 - 1269.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
M. Kolehmainen, M. I. J. Uusitupa, E. Alhava, M. Laakso, and H. Vidal
Effect of the Pro12Ala Polymorphism in the Peroxisome Proliferator-Activated Receptor (PPAR) {gamma}2 Gene on the Expression of PPAR{gamma} Target Genes in Adipose Tissue of Massively Obese Subjects
J. Clin. Endocrinol. Metab., April 1, 2003; 88(4): 1717 - 1722.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
H. J. Patel, M. G. Belvisi, D. Bishop-Bailey, M. H. Yacoub, and J. A. Mitchell
Activation of Peroxisome Proliferator-Activated Receptors in Human Airway Smooth Muscle Cells Has a Superior Anti-inflammatory Profile to Corticosteroids: Relevance for Chronic Obstructive Pulmonary Disease Therapy
J. Immunol., March 1, 2003; 170(5): 2663 - 2669.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Endocrinol.Home page
L. K. Juvet, S. M. Andresen, G. U. Schuster, K. T. Dalen, K. A. R. Tobin, K. Hollung, F. Haugen, S. Jacinto, S. M. Ulven, K. Bamberg, et al.
On the Role of Liver X Receptors in Lipid Accumulation in Adipocytes
Mol. Endocrinol., February 1, 2003; 17(2): 172 - 182.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
H. P. Koeffler
Peroxisome Proliferator-activated Receptor {gamma} and Cancers
Clin. Cancer Res., January 1, 2003; 9(1): 1 - 9.
[Abstract] [Full Text] [PDF]

Home page
 J. Am. Soc. Nephrol.Home page
M. Arici, R. Chana, A. Lewington, J. Brown, and N. J. Brunskill
Stimulation of Proximal Tubular Cell Apoptosis by Albumin-Bound Fatty Acids Mediated by Peroxisome Proliferator Activated Receptor-{gamma}
J. Am. Soc. Nephrol., January 1, 2003; 14(1): 17 - 27.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
F. Forcheron, A. Cachefo, S. Thevenon, C. Pinteur, and M. Beylot
Mechanisms of the Triglyceride- and Cholesterol-Lowering Effect of Fenofibrate in Hyperlipidemic Type 2 Diabetic Patients
Diabetes, December 1, 2002; 51(12): 3486 - 3491.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
C. Sewter, F. Blows, R. Considine, A. Vidal-Puig, and S. O'Rahilly
Differential Effects of Adiposity on Peroxisomal Proliferator-Activated Receptor {gamma}1 and {gamma}2 Messenger Ribonucleic Acid Expression in Human Adipocytes
J. Clin. Endocrinol. Metab., September 1, 2002; 87(9): 4203 - 4207.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
M. M. Meyer, K. Levin, T. Grimmsmann, N. Perwitz, A. Eirich, H. Beck-Nielsen, and H. H. Klein
Troglitazone Treatment Increases Protein Kinase B Phosphorylation in Skeletal Muscle of Normoglycemic Subjects at Risk for the Development of Type 2 Diabetes
Diabetes, September 1, 2002; 51(9): 2691 - 2697.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
D. Jung, M. Fried, and G. A. Kullak-Ublick
Human Apical Sodium-dependent Bile Salt Transporter Gene (SLC10A2) Is Regulated by the Peroxisome Proliferator-activated Receptor alpha
J. Biol. Chem., August 16, 2002; 277(34): 30559 - 30566.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
Y. Tamori, J. Masugi, N. Nishino, and M. Kasuga
Role of Peroxisome Proliferator-Activated Receptor-{gamma} in Maintenance of the Characteristics of Mature 3T3-L1 Adipocytes
Diabetes, July 1, 2002; 51(7): 2045 - 2055.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Endocrinol.Home page
I. Pineda Torra, Y. Jamshidi, D. M. Flavell, J.-C. Fruchart, and B. Staels
Characterization of the Human PPAR{alpha} Promoter: Identification of a Functional Nuclear Receptor Response Element
Mol. Endocrinol., May 1, 2002; 16(5): 1013 - 1028.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes CareHome page
C. Bouche, S. W. Rizkalla, J. Luo, H. Vidal, A. Veronese, N. Pacher, C. Fouquet, V. Lang, and G. Slama
Five-Week, Low-Glycemic Index Diet Decreases Total Fat Mass and Improves Plasma Lipid Profile in Moderately Overweight Nondiabetic Men
Diabetes Care, May 1, 2002; 25(5): 822 - 828.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
T. Tchkonia, N. Giorgadze, T. Pirtskhalava, Y. Tchoukalova, I. Karagiannides, R. A. Forse, M. DePonte, M. Stevenson, W. Guo, J. Han, et al.
Fat depot origin affects adipogenesis in primary cultured and cloned human preadipocytes
Am J Physiol Regulatory Integrative Comp Physiol, May 1, 2002; 282(5): R1286 - R1296.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
B. Brunmair, F. Gras, S. Neschen, M. Roden, L. Wagner, W. Waldhausl, and C. Furnsinn
Direct Thiazolidinedione Action on Isolated Rat Skeletal Muscle Fuel Handling Is Independent of Peroxisome Proliferator-Activated Receptor-{gamma}-Mediated Changes in Gene Expression
Diabetes, October 1, 2001; 50(10): 2309 - 2315.
[Abstract] [Full Text]

Home page
 Cancer Res.Home page
T. Ikezoe, C. W. Miller, S. Kawano, A. Heaney, E. A. Williamson, J. Hisatake, E. Green, W. Hofmann, H. Taguchi, and H. P. Koeffle
Mutational Analysis of the Peroxisome Proliferator-activated Receptor {{gamma}} Gene in Human Malignancies
Cancer Res., July 1, 2001; 61(13): 5307 - 5310.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
K.-i. Inoue, Y. Kawahito, T. Yoshikawa, H. Sano, J. L. Houghton, and M. T. Torosoff
Lipid-Lowering Agents and Artery Endothelial Function
Chest, June 1, 2001; 119(6): 1979 - 1980.
[Full Text] [PDF]

Home page
 JEMHome page
P. Desreumaux, L. Dubuquoy, S. Nutten, M. Peuchmaur, W. Englaro, K. Schoonjans, B. Derijard, B. Desvergne, W. Wahli, P. Chambon, et al.
Attenuation of Colon Inflammation through Activators of the Retinoid X Receptor (RXR)/Peroxisome Proliferator-activated Receptor {{gamma}} (PPAR{{gamma}}) Heterodimer: A Basis for New Therapeutic Strategies
J. Exp. Med., April 2, 2001; 193(7): 827 - 838.
[Abstract] [Full Text] [PDF]

Home page